144 related articles for article (PubMed ID: 26124315)
1. CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.
Akhter A; Mahe E; Street L; Pournazari P; Perizzolo M; Shabani-Rad MT; Stewart DA; Mansoor A
J Clin Pathol; 2015 Oct; 68(10):844-8. PubMed ID: 26124315
[TBL] [Abstract][Full Text] [Related]
2. A unique case of mantle cell lymphoma with an aberrant CD5-/CD10+ immunophenotype and typical morphology.
Sriganeshan V; Blom TR; Weissmann DJ
Arch Pathol Lab Med; 2008 Aug; 132(8):1346-9. PubMed ID: 18684040
[TBL] [Abstract][Full Text] [Related]
3. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.
Pizzi M; Agostinelli C; Righi S; Gazzola A; Mannu C; Galuppini F; Fassan M; Visentin A; Piazza F; Semenzato GC; Rugge M; Sabattini E
Histopathology; 2017 Nov; 71(5):769-777. PubMed ID: 28628241
[TBL] [Abstract][Full Text] [Related]
5. Mantle cell lymphoma with aberrant expression of CD10.
Zanetto U; Dong H; Huang Y; Zhang K; Narbaitz M; Sapia S; Kostopoulos I; Liu H; Du MQ; Bacon CM
Histopathology; 2008 Jul; 53(1):20-9. PubMed ID: 18518902
[TBL] [Abstract][Full Text] [Related]
6. Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence.
Pouliou E; Xochelli A; Kanellis G; Stalika E; Sutton LA; Navarro A; Agathangelidis A; Dimosthenous K; Anagnostopoulos A; Patsouris E; Korkolopoulou P; Sundstrom C; Ghia P; Ponzoni M; Sander B; Campo E; Rosenquist R; Hadzidimitriou A; Stamatopoulos K; Papadaki T
Am J Pathol; 2017 Jul; 187(7):1454-1458. PubMed ID: 28457696
[TBL] [Abstract][Full Text] [Related]
7. A unique case of blastoid variant of mantle cell lymphoma with an aberrant CD5-/CD10+/Bcl-6+/CD56+ immunophenotype: a case report.
Park S; Ko YH
Tumori; 2012; 98(4):e111-4. PubMed ID: 23052175
[TBL] [Abstract][Full Text] [Related]
8. BCL6, MUM1, and CD10 expression in mantle cell lymphoma.
Gualco G; Weiss LM; Harrington WJ; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):103-8. PubMed ID: 19826251
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Features and Treatment of CD10-Positive Mantle Cell Lymphoma: A Case Report and Review of Literature.
Hino C; Pham B; Gray AL; Wang J; Castillo DR; Akhtari M; Liu Y
Pathol Oncol Res; 2022; 28():1610588. PubMed ID: 36091937
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
[TBL] [Abstract][Full Text] [Related]
11. Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
Wehkamp U; Pott C; Unterhalt M; Koch K; Weichenthal M; Klapper W; Oschlies I
Am J Surg Pathol; 2015 Aug; 39(8):1093-101. PubMed ID: 26034867
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review.
Castillo DR; Park D; Jeon WJ; Joung B; Lee J; Yang C; Pham B; Hino C; Chong E; Shields A; Nguyen A; Brothers J; Liu Y; Zhang KK; Cao H
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373354
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma, blastoid variant, diagnosed on the basis of cytomorphology and flow cytometric immunophenotyping of the lymph node aspirate and peripheral blood.
Lee MJ; Kee KH; Jeon HJ
J Korean Med Sci; 2002 Apr; 17(2):173-8. PubMed ID: 11961299
[TBL] [Abstract][Full Text] [Related]
14. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous mantle cell lymphoma of the leg with blastoid morphology and aberrant immunophenotype: a diagnostic challenge.
Cesinaro AM; Bettelli S; Maccio L; Milani M
Am J Dermatopathol; 2014 Feb; 36(2):e16-8. PubMed ID: 23612032
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic characterization reveals new subsets of mantle cell lymphoma.
Thelander EF; Rosenquist R
Leuk Lymphoma; 2008 Jun; 49(6):1042-9. PubMed ID: 18452063
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic Variations in Mantle Cell Lymphoma and Their Impact on Clinical Behavior and Outcome.
Aqil B; Triska G; Frater J; Hassan A; Ruzinova MB; Cashen A; Reese Y; Kreisel F
Arch Pathol Lab Med; 2018 Oct; 142(10):1268-1274. PubMed ID: 29869903
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous blastoid mantle cell lymphoma-case report.
Estrozi B; Sanches JA; Varela PC; Bacchi CE
Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic variations in mantle cell lymphoma.
Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
